Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Shideng Bao, Qiulian Wu, Roger E. McLendon, +6

Nature

Genome InstabilityRadiation TherapyMedicineRadiation EffectGlioma Stem Cells +10

Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor

Shideng Bao, Qiulian Wu, Sith Sathornsumetee, +7

Cancer Research

Stem Cell BiologyGliomaTumor AngiogenesisTumor BiologyNeuro-oncology +15

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

Zhizhong Li, Shideng Bao, Qiulian Wu, +9

Cancer Cell

Redox RegulatorMedicineHypoxia (Medicine)Glioma Stem CellsStem Cell Research +4

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Ranjit K. Goudar, Qing Shi, Mark D. Hjelmeland, +13

Molecular Cancer Therapeutics

Neuro-oncologyMammalian TargetGliomaMedicineReceptor Tyrosine Kinase +11

A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Qing Shi, Anita B. Hjelmeland, Stephen T. Keir, +7

Molecular Carcinogenesis

Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro

Qing Shi, Sun-Han Zhang, L. Liu, +4

British Journal of Anaesthesia

Hypoxia-inducible FactorsGliomaMedicineGlioma Stem CellsStem Cell Research +8

MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R

Yi-Yuan Ge, Qing Shi, Zhiyuan Zheng, +4

Oncotarget

Loss of Phosphatase and Tensin Homologue Increases Transforming Growth Factor β–Mediated Invasion with Enhanced SMAD3 Transcriptional Activity

Anita B. Hjelmeland, Mark D. Hjelmeland, Qing Shi, +5

Cancer Research

MiR-650 inhibits proliferation, migration and invasion of rheumatoid arthritis synovial fibroblasts by targeting AKT2

Xiaoyan Xu, Haiyan Chen, Qin Zhang, +3

Biomedicine & Pharmacotherapy

The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion

Anita B. Hjelmeland, Kathryn P. Lattimore, Brian E. Fee, +8

Molecular Cancer Therapeutics